Oct. 28, 2026
Therapeutic Interventions for Genetic Hearing Loss: Inside the SKY-GJB2 Trial
Gene therapy is opening new possibilities for addressing the underlying causes of genetic hearing loss. Brian Taylor, AuD, is joined by Jodi Cook, PhD, CEO of Skylark Bio, and Alexa Kozak, AuD, to discuss emerging therapeutic interventions for inherited hearing loss, with a particular focus on GJB2-related hearing loss, commonly associated with the connexin 26 protein. They explain the role












